(Q39433792)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23594598%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

title

NF-κB and STAT3 inhibition as a therapeutic strategy in psoriasis: in vitro and in vivo effects of BTH (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23594598%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

0 references

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23594598%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

author name string

Rosa M Andrés

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23594598%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Pedro Navalón

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23594598%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Miguel Payá

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23594598%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

M Carmen Terencio

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23594598%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

language of work or name

English

0 references

publication date

17 April 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23594598%20AND%20SRC:MED&resulttype=core&format=json

Journal of Investigative Dermatology

28 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23594598%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

volume

133

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23594598%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23594598%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

page(s)

2362-2371

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23594598%20AND%20SRC:MED&resulttype=core&format=json

Signal transducer and activator of transcription-3, inflammation, and cancer: how intimate is the relationship?.

28 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.182

7 January 2021

Avarol inhibits TNF-alpha generation and NF-kappaB activation in human cells and in animal models.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.182

7 January 2021

Antipsoriatic effects of avarol-3'-thiosalicylate are mediated by inhibition of TNF-alpha generation and NF-kappaB activation in mouse skin

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.182

7 January 2021

Potential antipsoriatic effect of chondroitin sulfate through inhibition of NF-κB and STAT3 in human keratinocytes.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.182

7 January 2021

Effects of tumor necrosis factor-alpha (TNF alpha) in epidermal keratinocytes revealed using global transcriptional profiling

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.182

7 January 2021

IL-1RL2 and its ligands contribute to the cytokine network in psoriasis.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.182

7 January 2021

Comparisons of two in vitro cytotoxicity assays-The neutral red (NR) and tetrazolium MTT tests

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.182

7 January 2021

Psoriasis: dysregulation of innate immunity

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.182

7 January 2021

Double-blind, placebo-controlled, dose-escalation study to evaluate the pharmacologic effect of CP-690,550 in patients with psoriasis

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.182

7 January 2021

Antioxidant activity, lipid peroxidation and skin diseases. What's new.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.182

7 January 2021

Protein kinase C alpha-mediated chemotaxis of neutrophils requires NF-kappa B activity but is independent of TNF alpha signaling in mouse skin in vivo

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.182

7 January 2021

JAK3 inhibition significantly attenuates psoriasiform skin inflammation in CD18 mutant PL/J mice.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.182

7 January 2021

Toward the discovery of new agents able to inhibit the expression of microsomal prostaglandin E synthase-1 enzyme as promising tools in drug development

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.182

7 January 2021

The IL-23/Th17 axis in the immunopathogenesis of psoriasis

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.182

7 January 2021

Preclinical evaluation of local JAK1 and JAK2 inhibition in cutaneous inflammation.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.182

7 January 2021

TNF Inhibition Rapidly Down-Regulates Multiple Proinflammatory Pathways in Psoriasis Plaques

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.182

7 January 2021

Interleukin 6 is expressed in high levels in psoriatic skin and stimulates proliferation of cultured human keratinocytes

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.182

7 January 2021

Anti-inflammatory and analgesic activity of a novel inhibitor of microsomal prostaglandin E synthase-1 expression

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.182

7 January 2021

Synthesis and pharmacological evaluation of a selected library of new potential anti-inflammatory agents bearing the gamma-hydroxybutenolide scaffold: a new class of inhibitors of prostanoid production through the selective modulation of microsomal

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.182

7 January 2021

TPA induction leads to a Th17-like response in transgenic K14/VEGF mice: a novel in vivo screening model of psoriasis

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.182

7 January 2021

Psoriasis and the arachidonic acid cascade

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.182

7 January 2021

Mast cells and neutrophils release IL-17 through extracellular trap formation in psoriasis

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.182

7 January 2021

Differential expression of phosphorylated NF-kappaB/RelA in normal and psoriatic epidermis and downregulation of NF-kappaB in response to treatment with etanercept

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.182

7 January 2021

Stat3 as a therapeutic target for the treatment of psoriasis: a clinical feasibility study with STA-21, a Stat3 inhibitor.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.182

7 January 2021

Involvement of tumor necrosis factor (TNF)-alpha in phorbol ester 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced skin edema in mice

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.182

7 January 2021

https://api.crossref.org/works/10.1038%2FJID.2013.182

1 reference

7 January 2021

In vivo pharmacological disease models for psoriasis and atopic dermatitis in drug discovery

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.182

7 January 2021

Cytokines and anticytokines in psoriasis.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.182

7 January 2021

Inhibition of the NF-kappaB signaling pathway mediates the anti-inflammatory effects of petrosaspongiolide M.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.182

7 January 2021

Regulation at multiple levels of NF-kappaB-mediated transactivation by protein acetylation

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.182

7 January 2021

CCL27 expression is regulated by both p38 MAPK and IKKβ signalling pathways.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.182

7 January 2021

The Effects of IL-20 Subfamily Cytokines on Reconstituted Human Epidermis Suggest Potential Roles in Cutaneous Innate Defense and Pathogenic Adaptive Immunity in Psoriasis

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.182

7 January 2021

Stat3 links activated keratinocytes and immunocytes required for development of psoriasis in a novel transgenic mouse model

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.182

7 January 2021

Anti-inflammatory effects of tacalcitol (1,24(R)(OH)2D3, TV-02) in the skin of TPA-treated hairless mice

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.182

7 January 2021

NF-kappaB: a key role in inflammatory diseases

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.182

7 January 2021

Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23/IL-17 axis.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.182

7 January 2021

New biologic drugs get under the skin of psoriasis

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.182

7 January 2021

IL-22 and IL-20 are key mediators of the epidermal alterations in psoriasis while IL-17 and IFN-gamma are not.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.182

7 January 2021

Development of the IL-12/23 antagonist ustekinumab in psoriasis: past, present, and future perspectives--an update

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.182

7 January 2021